Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
This report contains market size and forecasts of Pimozide Tablet in global, including the following market information:
Global Pimozide Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pimozide Tablet Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pimozide Tablet companies in 2021 (%)
The global Pimozide Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1Mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pimozide Tablet include Teva, Par Pharmaceutical, Johnson & Johnson, Eumedica, Pharmascience, Domina Pharmaceuticals and Aa Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pimozide Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pimozide Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pimozide Tablet Market Segment Percentages, by Type, 2021 (%)
1Mg
2Mg
4Mg
Global Pimozide Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pimozide Tablet Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drugstores
Others
Global Pimozide Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pimozide Tablet Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pimozide Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pimozide Tablet revenues share in global market, 2021 (%)
Key companies Pimozide Tablet sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pimozide Tablet sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma